BILINSKY IGOR — SEC insider filings
SEC reporting owner CIK 1594604. 33 insider filings on record with FilingPulse; latest filed 2026-09-10.
Transaction summary — filings shown
Covers all 33 filings on record, filed 2021-02-16 to 2026-09-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 96.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Chief Operating Officer | 32 | — | — | 95 |
| Oncternal Therapeutics, Inc. (ONCT) | Chief Business Officer | 1 | — | — | 1 |
Insider filings — BILINSKY IGOR
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-10 | 4 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Option exercise (M): 7,813 @ $0 · Tax withholding (F): 3,976 @ $8.70 · Option exercise (M): 7,813 (derivative) @ $0 | EDGAR |
| 2026-09-03 | 4 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Option exercise (M): 8,789 @ $0 · Tax withholding (F): 4,472 @ $8.28 · Option exercise (M): 8,789 (derivative) @ $0 | EDGAR |
| 2026-06-09 | 4 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Option exercise (M): 7,813 @ $0 · Tax withholding (F): 3,976 @ $4.23 · Option exercise (M): 7,813 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Option exercise (M): 8,790 @ $0 · Tax withholding (F): 4,473 @ $3.96 · Option exercise (M): 8,790 (derivative) @ $0 | EDGAR |
| 2026-03-11 | 4 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Grant/award (A): 117,500 (derivative) @ $0 | EDGAR |
| 2026-03-06 | 4 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Option exercise (M): 31,246 @ $0 · Tax withholding (F): 16,628 @ $4.58 · Option exercise (M): 31,246 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Option exercise (M): 12,307 @ $0 · Tax withholding (F): 6,903 @ $3.79 · Option exercise (M): 8,790 (derivative) @ $0 · Option exercise (M): 3,517 (derivative) @ $0 | EDGAR |
| 2025-12-03 | 4 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Option exercise (M): 8,789 @ $0 · Tax withholding (F): 4,464 @ $2.23 · Option exercise (M): 3,516 @ $0 · Tax withholding (F): 1,786 @ $2.14 · Option exercise (M): 8,789 (derivative) @ $0 · Option exercise (M): 3,516 (derivative) @ $0 | EDGAR |
| 2025-09-04 | 4 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Option exercise (M): 12,306 @ $0 · Tax withholding (F): 6,250 @ $2.19 · Option exercise (M): 3,516 (derivative) @ $0 · Option exercise (M): 8,790 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Option exercise (M): 12,305 @ $0 · Tax withholding (F): 6,250 @ $1.76 · Option exercise (M): 3,516 (derivative) @ $0 · Option exercise (M): 8,789 (derivative) @ $0 | EDGAR |
| 2025-03-07 | 4 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Grant/award (A): 93,750 (derivative) @ $0 | EDGAR |
| 2025-03-05 | 4 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Option exercise (M): 62,106 @ $0 · Tax withholding (F): 33,302 @ $4.04 · Option exercise (M): 3,516 (derivative) @ $0 · Option exercise (M): 58,590 (derivative) @ $0 | EDGAR |
| 2025-01-16 | 4 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Option exercise (M): 2,813 @ $0 · Tax withholding (F): 1,578 @ $5.89 · Option exercise (M): 2,813 (derivative) @ $0 | EDGAR |
| 2024-12-04 | 4 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Option exercise (M): 3,516 @ $0 · Tax withholding (F): 1,784 @ $9.07 · Option exercise (M): 3,516 (derivative) @ $0 | EDGAR |
| 2024-10-16 | 4 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Option exercise (M): 2,813 @ $0 · Tax withholding (F): 1,428 @ $9.77 · Option exercise (M): 2,813 (derivative) @ $0 | EDGAR |
| 2024-09-05 | 4 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Option exercise (M): 3,516 @ $0 · Tax withholding (F): 1,784 @ $10.85 · Option exercise (M): 23,438 @ $0 · Tax withholding (F): 11,891 @ $10.85 · Option exercise (M): 3,516 (derivative) @ $0 · Option exercise (M): 23,438 (derivative) @ $0 | EDGAR |
| 2024-07-17 | 4 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Option exercise (M): 2,813 @ $0 · Tax withholding (F): 1,428 @ $8.68 · Option exercise (M): 2,813 (derivative) @ $0 | EDGAR |
| 2024-06-05 | 4 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Option exercise (M): 3,516 @ $0 · Tax withholding (F): 1,784 @ $8.37 · Option exercise (M): 3,516 (derivative) @ $0 | EDGAR |
| 2024-04-17 | 4 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Option exercise (M): 2,812 @ $0 · Tax withholding (F): 1,427 @ $11.89 · Option exercise (M): 2,812 (derivative) @ $0 | EDGAR |
| 2024-03-06 | 4 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Option exercise (M): 14,061 @ $0 · Tax withholding (F): 7,287 @ $16.96 · Option exercise (M): 14,061 (derivative) @ $0 | EDGAR |
| 2024-03-05 | 4 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Grant/award (A): 105,470 (derivative) @ $0 · Grant/award (A): 46,875 (derivative) @ $0 | EDGAR |
| 2024-01-18 | 4 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Option exercise (M): 2,813 @ $0 · Tax withholding (F): 1,577 @ $8.37 · Option exercise (M): 2,813 (derivative) @ $0 | EDGAR |
| 2023-10-18 | 4 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Option exercise (M): 2,813 @ $0 · Tax withholding (F): 1,395 @ $3.57 · Option exercise (M): 2,813 (derivative) @ $0 | EDGAR |
| 2023-07-17 | 4 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Option exercise (M): 2,813 @ $0 · Tax withholding (F): 1,395 @ $7.76 · Option exercise (M): 2,813 (derivative) @ $0 | EDGAR |
| 2023-04-18 | 4 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Option exercise (M): 2,812 @ $0 · Tax withholding (F): 1,395 @ $5.64 · Option exercise (M): 2,812 (derivative) @ $0 | EDGAR |
| 2023-03-06 | 4 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Grant/award (A): 42,190 (derivative) @ $0 · Grant/award (A): 84,380 (derivative) @ $0 | EDGAR |
| 2023-01-19 | 4 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Option exercise (M): 11,248 @ $0 · Tax withholding (F): 4,671 @ $6.43 · Option exercise (M): 11,248 (derivative) @ $0 | EDGAR |
| 2023-01-05 | 4 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Option exercise (M): 18,850 @ $0 · Tax withholding (F): 10,553 @ $6.11 · Option exercise (M): 18,850 (derivative) @ $0 | EDGAR |
| 2022-06-16 | 4 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Option exercise (M): 18,850 @ $0 · Tax withholding (F): 9,346 @ $7.73 · Grant/award (A): 18,850 (derivative) @ $0 | EDGAR |
| 2022-01-19 | 4 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Grant/award (A): 33,750 (derivative) @ $0 · Grant/award (A): 67,500 (derivative) @ $0 | EDGAR |
| 2021-06-16 | 4 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Grant/award (A): 37,700 (derivative) @ $0 | EDGAR |
| 2021-03-16 | 4 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2021-02-16 | 4 | Oncternal Therapeutics, Inc. (ONCT) | Grant/award (A): 130,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-02-16 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1594604 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs